Cognitive function in HIV-exposed uninfected children in rural Zimbabwe
Cognitive function in HIV-exposed uninfected children in rural Zimbabwe
批准号:
MR/X022005/1
负责人:
Andrew Prendergast
金额:
$139.58万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Two-thirds of children in sub-Saharan Africa do not develop to their full potential, meaning they will do less well at school, have lower adult IQ and poorer job prospects. Identifying the underlying reasons would allow us to intervene early to enhance their brain development, learning and life chances. 15 million children globally are HIV-exposed uninfected, or HEU, meaning they were born to mothers with HIV infection, but avoided being infected with HIV themselves. These HIV-negative children, born to HIV-positive mothers, have poorer child development at 2 years of age compared to children born to HIV-negative mothers, but we do not know why. We have been following a large group of children in rural Zimbabwe from birth, and our results show that 7 year old HEU children continue to have lower intelligence test scores than HIV-unexposed children. We now want to understand the range of brain functions that are affected, understand why this difference is still seen at school-age, and see whether an early life package of interventions (which improved test scores at age 2yrs) have a sustained benefit for HEU children by age 10 years. We will do detailed testing of children's brain function at age 10, through a range of tests and puzzles, an assessment of their language skills, and questionnaires about behavioural and mental health problems. In some children, we will measure their brain electrical patterns using a cap placed on the head with wires linked to a computer. By measuring electrical patterns in different parts of the brain while doing psychological tests, we can directly compare how the brain functions in HEU and HIV-unexposed children.We will then explore possible reasons for reduced cognition in HEU children. First, we believe HIV exposure disrupts some of the body's communication between the gut and the brain. This occurs partly through chemicals called metabolites which are produced by gut bacteria and are influenced by diet. We have shown that the types of gut bacteria in HEU children are different to HIV-unexposed children, and this may affect the metabolites they make, which in turn influences the way the brain develops. HEU children also have excess inflammation (the body's response to infection or injury) which may damage the developing brain. We will use stored blood samples (collected when these children were 18 months old) to compare metabolites, inflammation and markers of damage to nerve cells. Second, we believe the child's environment influences the way their brain develops, so we will collect information about the child's life, their caregiver's nurturing, and their household situation, to compare the living conditions of HEU and HIV-unexposed children. Finally, we will see whether a package of interventions, which were delivered to HEU children in the first 2 years of life, has a long-lasting benefit on their cognition at age 10 years. These children were randomised (like the flip of a coin) in early life to receive nutritional supplements or not, and improvements in household water, sanitation and hygiene (WASH) or not. HEU children who received both the nutritional supplements plus the improved WASH had much better test scores when we assessed their brain development at 2 years of age. Now we want to see if this effect lasts to 10 years and whether these interventions might have worked by improving the way the gut communicates and provides nutrients for the brain.If we find that nutrition and WASH interventions still have benefits at age 10, this provides powerful evidence for scaling up these strategies for all HIV-exposed children. If the early-life benefits that we saw are not sustained, we need to find new approaches. Either way, this project will discover factors in early life that need to be tackled to ensure that all children can become healthy and productive adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A community-designed play intervention to enhance early child development in rural Zimbabwe
-
批准号:MR/Y503290/1
-
项目类别:Research Grant
-
资助金额:$19.75万
-
财政年份:2023
-
负责人:Andrew Prendergast
-
依托单位:
Physiological function in children with stunting in rural Zimbabwe
-
批准号:MR/Y003543/1
-
项目类别:Research Grant
-
资助金额:$121.68万
-
财政年份:2023
-
负责人:Andrew Prendergast
-
依托单位:
The impact of microbial and inflammatory exposures on birth outcomes in rural Zimbabwe
-
批准号:MR/T039337/1
-
项目类别:Research Grant
-
资助金额:$149.73万
-
财政年份:2021
-
负责人:Andrew Prendergast
-
依托单位:
Child Health, Agriculture and Integrated Nutrition (CHAIN): a randomized trial to close the nutrient gap in rural Zimbabwe
-
批准号:BB/S013997/1
-
项目类别:Research Grant
-
资助金额:$236.88万
-
财政年份:2019
-
负责人:Andrew Prendergast
-
依托单位:
Interdisciplinary interventions for stunting and wasting in Zimbabwe, Zambia and Pakistan
-
批准号:MC_PC_MR/R019436/1
-
项目类别:Research Grant
-
资助金额:$24.93万
-
财政年份:2018
-
负责人:Andrew Prendergast
-
依托单位:
Mechanisms underlying enhanced infection prophylaxis for advanced HIV in Africa
-
批准号:MR/P022251/1
-
项目类别:Research Grant
-
资助金额:$105.25万
-
财政年份:2017
-
负责人:Andrew Prendergast
-
依托单位:
The role of enteropathy in the pathogenesis of severe acute malnutrition in HIV-infected African children
-
批准号:MR/K012711/1
-
项目类别:Research Grant
-
资助金额:$98.54万
-
财政年份:2014
-
负责人:Andrew Prendergast
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
-
批准号:82371755
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王秦兰
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位: